Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Roujian Lu1 Xiang Zhao1 Juan Li2 Peihua Niu1 Bo Yang3 Honglong Wu4 Wenling Wang1 Hao Song5 Baoying Huang1 Na Zhu1 Yuhai Bi6,7 Xuejun Ma1 Faxian Zhan3 Liang Wang6,7 Tao Hu2 Hong Zhou2 Zhenhong Hu8 Weimin Zhou1 Li Zhao1 Jing Chen9 Yao Meng1 Ji Wang1 Yang Lin4 Jianying Yuan4 Zhihao Xie4 Jinmin Ma4 William J Liu1 Dayan Wang1 Wenbo Xu1 Edward C Holmes10 George F Gao11,6,7 Guizhen Wu1 Weijun Chen4 Weifeng Shi12,13 Wenjie Tan11,14,15
Affiliations 15 institutions
  1. NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  2. Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai'an, China.
  3. Division for Viral Disease Detection, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  4. BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China.
  5. Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
  6. Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
  7. Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, China.
  8. Central Theater, People's Liberation Army General Hospital, Wuhan, China.
  9. Key Laboratory of Laboratory Medicine, Ministry of Education, and Zhejiang Provincial Key Laboratory of Medical Genetics, Institute of Medical Virology, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  10. Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.
  11. NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
  12. Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai'an, China
  13. The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan, China. Electronic address: [email protected].
  14. Central Theater, People's Liberation Army General Hospital, Wuhan, China
  15. Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China. Electronic address: [email protected].

Abstract

In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed. We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus. The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99·98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues. 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensin-converting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation. National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Shandong First Medical University.

Supporting text Virus Host Location
Genome, Viral 317 Betacoronavirus 78 Bronchoalveolar Lavage Fluid 3 China 229 Coronavirus Infections 171 COVID-19 425 Disease Reservoirs 149 DNA, Viral 39 Genomics 32 High-Throughput Nucleotide Sequencing 39 Humans 1440 Phylogeny 805 Pneumonia, Viral 42 Receptors, Virus 204 SARS-CoV-2 453 Sequence Alignment 51

Evidence records

3 total
Zoonotic Surveillance
1 records · 1 evidence types
Evidence type
1 records
OVE3626
Key finding

Infectious 2019 novel coronavirus (2019‑nCoV) was successfully cultured and isolated from bronchoalveolar lavage fluid samples obtained from nine hospitalized patients in Wuhan.

Virus
Host
Location
Not specified
Supporting text

We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients.

Sample type
bronchoalveolar lavage fluid
Transmission Evidence
1 records · 1 evidence types
Evidence type
1 records
OVE3627
Key finding

An outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan involved over 2000 confirmed human cases with established human-to-human transmission by late January 2020.

Virus
Host
Location
Supporting text

As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed.

Method
epidemiological investigation | case confirmation
Transmission direction
human-to-human
Geographic raw
Wuhan, China
Country inferred
CHN
Outbreak time
Jan 26, 2020
Outbreak scale
more than 2000 cases
Genomic Evolution
1 records · 1 evidence types
Evidence type
1 records
OVE3628
Key finding

Phylogenetic analysis placed 2019-nCoV within the Sarbecovirus subgenus and showed about 88% genome identity and close evolutionary relationship to the bat-derived coronaviruses bat-SL-CoVZC45 and bat-SL-CoVZXC21.

Virus
Host
Location
Not specified
Supporting text

Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV.

Genes or proteins
genome
Analysis methods
phylogenetic analysis | comparative genomic analysis